Manufacturing news briefs – stories you might have missed
Covid-19 treatment tests begin for Noxopharm’s Veyonda Drug developer Noxopharm’s Veyonda drug has been tested as a treatment for Covid-19 on its first human patients. The Phase 1 clinical trials of Veyonda, an experimental anti-cancer formulation of the drug idronoxi, is being conducted in a number of hospitals in Eastern Europe. This came after research…